In contrast to type 1 diabetes, which is characterised by autoimmune beta-cell destruction, and type 2 diabetes, which is largely associated with insulin resistance and environmental factors, MODY arises from pathogenic variants in genes that regulate beta-cell function, insulin secretion, or glucose sensing [2,3]. This evidence concerns the gene INS and type 1 diabetes mellitus.